what is similar to glp-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 drugs for weight loss:

The adverse reactions that occurred in at least two (6.1%) REPATHA-treated patients, and more frequently than in placebo-treated patients, included: Upper respiratory tract infection (9.1% versus 6.3%) Influenza (9.1% versus 0%) Gastroenteritis (6.1% versus 0%) Nasopharyngitis (6.1% versus 0%) In a multicenter, open-label 5-year extension study, 106 patients with HoFH, including 14 pediatric patients, received 420 mg of REPATHA subcutaneously once monthly or every 2 weeks [see Clinical Studies (14)]

53 Moreover, there was a linear relationship between HRQoL and BMI

We only increase the dose if progress has completely stalled and other supportive measures have been exhausted

People with microbiomes enriched for TMA producing bacteria can also make more TMA from the same dose of L-carnitine and thus become symptomatic